Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The low-dose GSH group also experienced significant increases in GSH levels, specifically showing a 17% increase in blood and a 29% increase in erythrocytes at six months compared to baseline
[PMID: 7178214] PubMed record related to this compound for laboratory literature review
Unlike growth hormone secretagogues that rely on stimulating the pituitary first, IGF-1 LR3 works downstream at the tissue level
Peptide Amount % of Blend GHK-Cu (copper tripeptide) 50 mg 62.5% BPC-157 10 mg 12.5% TB-500 (thymosin beta-4 fragment) 10 mg 12.5% KPV (lysine-proline-valine) 10 mg 12.5% Total 80 mg 100% In a research context, each component maps to a distinct literature: GHK-Cu is the most-studied copper tripeptide, investigated for extracellular matrix remodeling and collagen-related signaling (Pickart & Margolina, 2018)
Heller, R
